Quest Diagnostics
DGX
#1094
Rank
ยฃ15.30 B
Marketcap
ยฃ136.89
Share price
-0.91%
Change (1 day)
10.07%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Quest Diagnostics (DGX) - Net assets

Net assets on the balance sheet as of September 2025 : ยฃ5.53 Billion

According to Quest Diagnostics 's latest financial reports the company has ยฃ5.53 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Quest Diagnostics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$ยฃ5.49 B9.08%
2023-12-31$ยฃ5.03 B1.46%
2022-12-31$ยฃ4.96 B2.14%
2021-12-31$ยฃ4.86 B-3.84%
2020-12-31$ยฃ5.05 B15.03%
2019-12-31$ยฃ4.39 B4.39%
2018-12-31$ยฃ4.21 B13.01%
2017-12-31$ยฃ3.72 B-2.96%
2016-12-31$ยฃ3.83 B18.94%
2015-12-31$ยฃ3.22 B16.05%
2014-12-31$ยฃ2.78 B15.47%
2013-12-31$ยฃ2.40 B-7%
2012-12-31$ยฃ2.58 B8.36%
2011-12-31$ยฃ2.39 B-8.99%
2010-12-31$ยฃ2.62 B5.94%
2009-12-31$ยฃ2.47 B0.78%
2008-12-31$ยฃ2.45 B46.99%
2007-12-31$ยฃ1.67 B8.56%
2006-12-31$ยฃ1.54 B-3.8%
2005-12-31$ยฃ1.60 B34.4%
2004-12-31$ยฃ1.19 B-10.95%
2003-12-31$ยฃ1.33 B21.35%
2002-12-31$ยฃ1.10 B19.73%
2001-12-31$ยฃ0.92 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
LabCorp
LH
ยฃ6.53 B 18.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
ยฃ3.84 M-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
ยฃ0.62 B-88.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
ยฃ32.55 M-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
ยฃ2.73 B-50.52%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands